Expect gradual changes in cravings, digestion, and energy rather than overnight weight loss
Serious Adverse Reactions: Identification and Management While less common, certain adverse reactions require immediate medical attention, including: Hypotension, which may manifest as dizziness or fainting
You should get about 12 bites
Pending regulatory approval, Novo Nordisk announced that semaglutide could become the first oral formulation of a glucagon-like peptide-1 (GLP-1) indicated for chronic weight management

You may be suitable for the Wegovy pill if you are an adult with: A BMI of 30 or above (clinically classified as obesity), or A BMI of 27 or above with at least one weight-related health condition such as high blood pressure, raised cholesterol, type 2 diabetes, prediabetes or obstructive sleep apnoea The Wegovy pill is not suitable if you: Are pregnant, breastfeeding or planning a pregnancy Have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Are allergic to semaglutide or any of the inactive ingredients Tell your doctor, who will assess whether it is appropriate, if you: Have a history of pancreatitis or severe gastrointestinal disease Have gallbladder problems or severe kidney disease The OASIS 4 trial that supported the UK approval did not include people with type 2 diabetes